FOXM1 is a transcription factor that plays a critical role in regulating cell proliferation, cell cycle progression, and DNA repair. It is overexpressed in a variety of cancers, including breast, lung, and pancreatic cancer, and is associated with poor patient outcomes. Research in the field of FOXM1 focuses on understanding the mechanisms by which it promotes tumor growth and metastasis, as well as developing targeted therapies to inhibit its activity. Additionally, FOXM1 has been identified as a potential biomarker for cancer prognosis and as a therapeutic target for novel cancer treatments.